Suchen
Sanofi SA
SNYZur Watchlist hinzufügen
44.260USD
-0.070-0.16%
Handelsschluss 09-04 16:00（ET）
105.99BMarktkapitalisierung
12.30KGV TTM
mehr Informationen über Sanofi SA Unternehmen
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Sanofi SA Profil
BörsenkürzelSNY
Name des UnternehmensSanofi SA
IPO-datumJul 01, 2002
CEOHudson (Paul)
Anzahl der mitarbeiter84587
WertpapierartDepository Receipt
GeschäftsjahresendeJul 01
Addresse46 Avenue de la Grande Armee
StadtPARIS
BörseNASDAQ OMX - NASDAQ BASIC
LandFrance
Postleitzahl75017
Telefon33153774000
Websitehttps://www.sanofi.com/
BörsenkürzelSNY
IPO-datumJul 01, 2002
CEOHudson (Paul)
Führungskräfte von Sanofi SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Ms. Rachel Duan
Ms. Rachel Duan
Independent Director
Independent Director
--
--
Ms. Lise Kingo
Ms. Lise Kingo
Independent Director
Independent Director
--
--
Ms. Natalie Bickford
Ms. Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Chief People Officer, Executive Vice President, Member of the Executive Committee
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Belen Garijo, M.D.
Dr. Belen Garijo, M.D.
Chief Executive Officer, Member of the Executive Committee, Director
Chief Executive Officer, Member of the Executive Committee, Director
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Mr. Patrick Kron
Mr. Patrick Kron
Independent Director
Independent Director
--
--
Mr. Christophe Babule
Mr. Christophe Babule
Director
Director
--
--
Mr. Paul Hudson, Ph.D.
Mr. Paul Hudson, Ph.D.
Chief Executive Officer, Executive Director, Member of the Executive Committee
Chief Executive Officer, Executive Director, Member of the Executive Committee
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Sanofi SA?
Die fünf größten Anteilseigner von Sanofi SA sind: Mr. Olivier Charmeil
Wie viele Institutionen halten Anteile an Sanofi SA (SNY)?
Mit Stand vom 2026Q1 halten 1330 Institutionen Anteile an Sanofi SA, mit einem Gesamtmarktwert von etwa 225.52M, was 9.34% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -36323619.00 gestiegen.